Publication Cover
Hemoglobin
international journal for hemoglobin research
Volume 33, 2009 - Issue sup1
183
Views
13
CrossRef citations to date
0
Altmetric
PROCEEDINGS OF THE 1ST PAN-MIDDLE EASTERN CONFERENCE ON HAEMOGLOBINOPATHIES DAMASCUS (SYRIA), 1–2 MAY, 2009 GUEST EDITORS: MICHAEL ANGASTINIOTIS AND ANDROULLA ELEFTHERIOUThe Fifth Section: Endocrine and Liver Complications

Osteopenia–Osteoporosis Syndrome in Patients with Thalassemia: Understanding of Type of Bone Disease and Response to Treatment

&
Pages S136-S138 | Published online: 13 Dec 2009

REFERENCES

  • Sambrook P, Cooper C. Osteoporosis. Lancet. 2006;367(9527):2010–2018, review.
  • Chatterjee RGM, Helal MA. Hypogonadism is a key contributor to the severity of osteoporosis in thalassaemic patients. 10th International Federation Conference (TIF) October 18–21; 2001.
  • Chatterjee R, Katz M. Reversible hypogonadotrophic hypogonadism in sexually infantile male thalassaemic patients with transfusional iron overload. Clin Endocrinol (Oxf). 2000;53(1):33–42.
  • Borgna-Pignatti C. Thalassemia. A few new tiles in a large mosaic. Haematologica. 2006;91(9):1159–1161, review.
  • Chan YL, Pang LM, Chik KW, Cheng JC, Li CK. Patterns of bone diseases in transfusion-dependent homozygous thalassaemia major: predominance of osteoporosis and desferrioxamine-induced bone dysplasia. Pediatr Radiol. 2002;32:492–497.
  • Morabito N, Gaudio A, Lasco A, et al. Osteoprotegerin and RANKL in the pathogenesis of thalassemia-induced osteoporosis: new pieces of the puzzle. J Bone Miner Res. 2004;19:722–727.
  • Voskaridou E, Terpos E, Spina G, et al. Pamidronate is an effective treatment for osteoporosis in patients with beta-thalassaemia. Br J Haematol. 2003;123:730–737.
  • Lasco A, Morabito N, Gaudio A, Buemi M, Wasniewska M, Frisina N. Effects of hormonal replacement therapy on bone metabolism in young adults with beta-thalassemia major. Osteoporos Int. 2001;12:570–575.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.